Top drug distributors in talks to settle opioid litigation for $18 billion, report says

Business

State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic.

The potential settlement, according to the Wall Street Journal, would require McKesson Corp., AmerisourceBergen Corp. and Cardinal Health to collectively pay the $18 billion over 18 years. Drugmaker Johnson & Johnson is also involved in the discussions to pay extra money, the WSJ reported, citing people familiar with the discussions. 

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

Why Do We Need Public Companies To Hand Out Free Money?
A Neuroscientist’s Prescription For A Brain In Menopause
How an industrial district is transforming into a bustling business hub
The ‘invincible teen consumer’ is back. Abercrombie & Fitch CEO says recovery better than expected
Top 10 Cheapest Cities to Retire in the United States (Part 1)

Leave a Reply

Your email address will not be published. Required fields are marked *